The revised capex is Rs. 745 crore and the facility is expected to be operational by December 2026
SRF Ltd.'s board has approved a revised capital expenditure proposal for setting up a facility dedicated to the production of specialty fluoropolymers.
The decision follows strategic agreements with The Chemours Company for manufacturing, supply, and distribution partnerships.
The revised capex is Rs. 745 crore and the facility is expected to be operational by December 2026.
Subscribe to our newsletter & stay updated.
_195_291.jpg)
